CDKN2A and lung carcinoma: Moreover, qPCR analysis revealed that overexpression of SLC16A4 upregulated the expression levels of CDKN1A and CDKN2A in A549 and H1299 cells, suggesting that SLC16A4 may suppress lung cancer cell proliferation by regulating the cell cycle (Figure 14E,F).